To this end, we analyzed transcriptomic data from KP tumors with acquired resistance to anti–PD-L1 and discovered the enzyme ATX to be significantly upregulated in an acquired resistance setting and in the newly developed, intrinsically resistant tumor models. Here, ENPP2 is linked to neoplasm.